FrederickRAhmannMD

Oncology • Tucson, AZ

Professor of Medicine, University Ariz College of Medicine

Join to view full profile

Are you Dr. Ahmann?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 50 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
3838 N Campbell Ave
Tucson, AZ 85719
Phone+1 520-694-2873
Is this information wrong?

Summary

Dr. Frederick Ahmann, MD is an oncologist in Tucson, Arizona. He is currently licensed to practice medicine in Arizona. He is affiliated with Banner - University Medical Center Tucson, Tucson VA Medical Center, and Banner - University Medical Center South.

Education & Training

University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1978 - 1980
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1974 - 1977
University of Missouri-Columbia School of MedicineClass of 1974

Certifications & Licensure

AZ State Medical License 1978 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2006-2014
Top Doctors:Arizona State Castle Connolly, 2013
America's Top Doctors for Cancer Castle Connolly, 2005-2013

Clinical Trials

Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate Start of enrollment: 2007 Mar 01
Completed
Phase 1
Selenium in Treating Patients With Prostate Cancer Start of enrollment: 2002 Aug 01
Completed
Phase 2
Selenium in Preventing Prostate Cancer Start of enrollment: 2001 Aug 01
Completed
Phase 3

Publications & Presentations

PubMed

691 citations
Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,63...
William J Catalona, Jerome P Richie, Frederick R Ahmann, M'Liss A Hudson, Peter T Scardino, Robert C Flanigan, Jean B DeKernion, Timothy L Ratliff, Louis R Kavoussi, B...> ;The Journal of Urology. 2017 Feb 1
Mixed Germ Cell Testicular Cancer with Left Ventricular Metastasis Presenting with Embolic Stroke and Small Bowel Tumor Seeding
Srinath Sundararajan, Beth L. Braunhut, Frederick R. Ahmann, Amit Agarwal> ;Case Reports in Oncological Medicine. 2014 Jun 18
68 citations
Phase 3 clinical trial investigating the effect of selenium supplementation in men at high risk for prostate cancer
Amit M. Algotar, M. Suzanne Stratton, Frederick R. Ahmann, James Ranger-Moore, Raymond B. Nagle, Patricia A. Thompson, Elizabeth H. Slate, Chiu H. Hsu, Bruce L. Dalkin...> ;The Prostate. 2013 Feb 15
1 citations
Differences in characteristics of men with localised prostate cancer who demonstrate low, intermediate or high prostate-specific antigen velocity.
Amit M. Algotar, Patricia A. Thompson, J. Ranger-Moore, M. S. Stratton, C. H. Hsu, Frederick R. Ahmann, Ray B. Nagle, S. P. Stratton> ;Internal Medicine Journal. 2012 Apr 1
87 citations
Randomized, Double-Blind, Placebo-Controlled Trial of Polyphenon E in Prostate Cancer Patients before Prostatectomy: Evaluation of Potential Chemopreventive Activities
Mike M. Nguyen, Frederick R. Ahmann, Raymond B. Nagle, Chiu Hsieh Hsu, Joseph A. Tangrea, Howard L. Parnes, Mitchell H. Sokoloff, Matthew B. Gretzer, H-H. Sherry Chow> ;Cancer Prevention Research. 2012 Feb 1
7 citations
Association of obesity and smoking with PSA and PSA velocity in men with prostate cancer.
Amit M. Algotar, Steven P. Stratton, James Ranger-Moore, M. Suzanne Stratton, C-H Hsu, Frederick R. Ahmann, Raymond B. Nagle, Patricia A. Thompson> ;American Journal of Men's Health. 2011 May 1
9 citations
Dose-dependent effects of selenized yeast on total selenium levels in prostatic tissue of men with prostate cancer.
Amit M. Algotar, M. S. Stratton, Min Jian Xu, Bruce L. Dalkin, Ray B. Nagle, Chiu Hsieh Hsu, Frederick R. Ahmann, Larry C. Clark, Steven P. Stratton> ;Nutrition and Cancer. 2010 Dec 1
15 citations
No Effect of Selenium Supplementation on Serum Glucose Levels in Men with Prostate Cancer
Amit M. Algotar, M. S. Stratton, Steven P. Stratton, Chiu Hsieh Hsu, Frederick R. Ahmann> ;The American Journal of Medicine. 2010 Aug 1
35 citations
Oral Selenium Supplementation Has No Effect on Prostate-Specific Antigen Velocity in Men Undergoing Active Surveillance for Localized Prostate Cancer
M. Suzanne Stratton, Amit M. Algotar, James Ranger-Moore, Steven P. Stratton, Elizabeth H. Slate, Chiu Hsieh Hsu, Patricia A. Thompson, Larry C. Clark, Frederick R. Ah...> ;Cancer Prevention Research. 2010 Aug 1
22 citations
Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity
Amit M. Algotar, Patricia A. Thompson, James Ranger-Moore, M. Suzanne Stratton, Chiu Hsieh Hsu, Frederick R. Ahmann, Raymond B. Nagle, Steven P. Stratton> ;The Prostate. 2010 Jun 1
Phase IIb clinical trial of selenium in prostate cancer patients on active surveillance.
Stratton M, Algotar AM, Ranger-Moore J, Slate E, Hsu P, Stratton SP, Thompson PA, Ahmann FR> ;J. Clin. Oncol.. 2008-05-20
69 citations
Efficacy and Safety of Single-Agent Pertuzumab (rhuMAb 2C4), a Human Epidermal Growth Factor Receptor Dimerization Inhibitor, in Castration-Resistant Prostate Cancer A...
David B. Agus, Christopher Sweeney, Michael J. Morris, David S. Mendelson, Douglas G. McNeel, Frederick R. Ahmann, Jin Wang, Mika K. Derynck, Kimmie Ng, Benjamin Lyons...> ;Journal of Clinical Oncology. 2007 Feb 9
233 citations
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ...
Tomasz M. Beer, Christopher W. Ryan, Peter Venner, Daniel P. Petrylak, Gurkamal Chatta, J. Dean Ruether, Charles H. Redfern, Louis Fehrenbacher, Mansoor N. Saleh, Davi...> ;Journal of Clinical Oncology. 2007 Feb 9
13 citations
Coccidioidomycosis of the prostate: a determination of incidence, report of 4 cases, and treatment recommendations
J. Paul Yurkanin, Frederick R. Ahmann, Bruce L. Dalkin> ;The Journal of Infection. 2006 Jan 1
Efficacy and safety of single agent pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in hormone refractory prostate cancer after failure of taxane-based therapy.
Agus DB, Sweeney CJ, Morris M, Mendelson D, McNeel DG, Ahmann F, Wang J, Derynck MK, Kattan MW, Scher HI> ;J. Clin. Oncol.. 2005-06-01
Phase I trial of irofulven (MGI 114) plus docetaxel in advanced cancers.
Ahmann FR, Culine S, Wilding G, Papadopoulos K, Raftopoulos H, Duvillie L, Weems G, Puzon C, Shah A, Terret C> ;J. Clin. Oncol.. 2005-06-01
32 citations
Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study.
M. S. Stratton, Mary E. Reid, G. Schwartzberg, F. E. Minter, B. K. Monroe, David S. Alberts, James R. Marshall, F. R. Ahmann> ;Anti-Cancer Drugs. 2003 Sep 1
29 citations
Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study.
M. S. Stratton, Mary E. Reid, G. Schwartzberg, F. E. Minter, B. K. Monroe, David S. Alberts, James R. Marshall, F. R. Ahmann> ;Anti-Cancer Drugs. 2003 Sep 1
73 citations
Low bone density and high percentage of body fat among men who were treated with androgen deprivation therapy for prostate carcinoma.
Zhao Chen, Michael Maricic, Paul L. Nguyen, Frederick R. Ahmann, Roberta Bruhn, Bruce L. Dalkin> ;Cancer. 2002 Nov 15
2 citations
Prostatic asymmetry as a risk factor for prostatic carcinoma: serial prostate-specific antigen monitoring and cancer detection.
Jr Jg Hansen, Bruce L. Dalkin, CH Harris, Cynthia S. Johnson, Frederick R. Ahmann> ;British Journal of Urology. 1997 Jun 1
10 citations
Ketoconazole-induced adrenal crisis in a patient with metastatic prostatic adenocarcinoma: case report and review of the literature.
Russell G. Sarver, Bruce L. Dalkin, Frederick R. Ahmann> ;Urology. 1997 May 1
20 citations
PROSPECTIVE LONGITUDINAL EVALUATION OF MEN WITH INITIAL PROSTATE SPECIFIC ANTIGEN LEVELS OF 4.0 NG./ML. OR LESS
Clifford H. Harris, Bruce L. Dalkin, Elleen Martin, Phyllis C. Marx, Frederick R. Ahmann> ;The Journal of Urology. 1997 May 1
26 citations
Tin-117m(4+)DTPA: pharmacokinetics and imaging characteristics in patients with metastatic bone pain.
G. T. Krishnamurthy, F. M. Swailem, Suresh C. Srivastava, Harold L. Atkins, Simpson Lj, Walsh Tk, Ahmann Fr, G.E. Meinken, Shah Jh> ;Journal of Nuclear Medicine. 1997 Feb 1
62 citations
Randomized Study of Neoadjuvant Testicular Androgen Ablation Therapy Before Radical Prostatectomy in Men with Clinically Localized Prostate Cancer
Bruce L. Dalkin, Frederick R. Ahmann, Raymond B. Nagle, Cynthia S. Johnson> ;The Journal of Urology. 1996 Apr 1
3 citations
Phase II trial of CHIP for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group Study.
M E Marshall, M K Wolf, E D Crawford, G R Weiss, F Ahmann, F J Meyers, B Blumenstein, M Eisenberger, A B Einstein> ;American Journal of Clinical Oncology. 1995 Oct 1
Join now to see all

Hospital Affiliations

Banner - University Medical Center SouthTucson, Arizona
Banner - University Medical Center TucsonTucson, Arizona
Tucson VA Medical CenterTucson, Arizona